Log In
Sign Up
Epirubicin
Indications
Adjuvant therapy in patients with evidence of axillary node tumor involvement following resection of primary breast cancer.
Dose/Application
IV 100-120mg/m2, given on Day 1 of cycle or divided into 2 doses and given on Day 1 and Day 8. It is repeated every 21–28 days for 6 cycles [in combination with other chemotherapy agents]. Consult specialist literature for further information.
Mode of action
Precautions
Contraindications
Side Effects
Pregnancy risk
Special information
Brands containing this Ingredient
Name Form. Strength Pack Price Insert Manufacturer Distributor
Adricin. inj 10mg/5mL 1 KES700.00
Adricin. inj 50mg/25mL 1 KES4000.00
Farmorubicin. inj 50mg 1 KES3,205.00
Drug Index 2.0 is here
Our new update features a more powerful search feature and easier login. Having any issues? Contact us today. Contact Us